Clinical trial
LIMItIng AAA With meTformin (LIMIT) Trial
NCT04500756 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- LIMItIng AAA With meTformin (LIMIT) Trial
- Lead sponsor
- Stanford University
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- February 28, 2022
- Completion date
- June 30, 2028
- Enrollment
- 314 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
abdominal aortic aneurysm